Article

Microkeratome produces consistent flaps for custom surgery

San Diego-The Amadeus microkeratome (AMO) produces consistent flaps and offers a number of variables that can be controlled by surgeons, noted Robert Weinstock, MD.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
Related Content
Nicox and Kowa sign agreement for exclusive rights to glaucoma treatment NCX 470
July 20th 2025

Nicox and Kowa sign agreement for exclusive rights to glaucoma treatment NCX 470

3 Things You Should Know About the GA Pipeline
June 4th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

OKYO Pharma announces positive results from phase 2 trial of urcosimod for neuropathic corneal pain
July 18th 2025

OKYO Pharma announces positive results from phase 2 trial of urcosimod for neuropathic corneal pain

Patient-Centered Treatment Strategies in the Management of nAMD and DME
May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

Harrow enters into agreement with Samsung Bioepis for commercial rights to its ophthalmology biosimilar portfolio
July 17th 2025

Harrow enters into agreement with Samsung Bioepis for commercial rights to its ophthalmology biosimilar portfolio

AAVantgarde Bio receives IND clearance for AAVB-039
July 17th 2025

AAVantgarde Bio receives IND clearance for AAVB-039

© 2025 MJH Life Sciences

All rights reserved.